Dr. Trusheim’s research interests include Phase II and Phase III trials for experimental therapeutics for brain tumors at Virginia Piper Cancer Institute, Abbott Northwestern Hospital and the University of Minnnesota. Dr. Trusheim serves as the local Principal Investigator for several Industry sponsored therapeutic trials for Grade IV gliomas. A Phase II clinical trial for glioblastoma treatment via vaccine therapy is currently open at Abbott Northwestern Hospital. There are also several RTOG and CCOP studies for a variety of tumor types open at Abbott. He is also involved in a Phase II radioactive monoclonal antibody trial for high grade tumors at the University of Minnesota.
In addition, Dr. Trusheim’s translation research projects (in collaboration with the Translational Genomics Research Institute, Phoenix, AZ) include studies on genetics of CNS metastasis of solid tumors and pathways of glioma invasion to the brain.